REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/17/2026
Back to search
Official data from USPTO
GENEHOME BUILT BY BLUEBIRD BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
08/17/2026
Trademark type
Combined
Nice classes
35, 41
Filing date
08/28/2020
Registration date
08/17/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2021
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
98
Owner location
US
Examiner
CROSS, TRACY L
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a blue and orange DNA strand design under a blue inverted V design, to the left of the stylized term "GENEHOME" in blue, above the wording "BUILT BY BLUEBIRD BIO" in blue.
Holders and representatives
Holders
Genetix Biotherapeutics, Inc.
bluebird bio, Inc.
bluebird bio, Inc.
Bluebird Bio (UK) Ltd.
Representatives
Christopher K. Albert Hamilton, Brook, Smith & Reynolds, P.C.
Technical classification
Nice Classes
Class 35Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public awareness of gene therapy; Promoting public awareness of gene therapy by means of public advocacy through advertising services; Promoting the interests of gene therapist by means of public advocacy; advertising services in the field of gene therapy; provision of informationconsultancy and advice relating to the aforesaid
Class 41
Educational activities and services relating to gene therapyproviding classesworkshops and/or seminars; arranging and conducting of conferencesseminarssymposiumsworkshopsin-person educational forums relating to gene therapy; teaching and instruction services relating to gene therapy; providing prerecorded audiovisualaudio-visual educational programsnot downloadablevia video-on-demand servicesthat relate to gene therapy
Publications
History of USPTO decisions and trademark events.
37 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/18/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/18/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/18/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/13/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/23/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/26/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/20/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
01/28/2022
FIMP
FINAL DISPOSITION PROCESSED
01/28/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/17/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/09/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/17/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/01/2021
PUBO
PUBLISHED FOR OPPOSITION
06/01/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/12/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/27/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/14/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/13/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/06/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/06/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/27/2021
RFNT
REFUSAL PROCESSED BY IB
02/14/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/28/2021
RFRR
REFUSAL PROCESSED BY MPU
01/28/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/12/2021
CNRT
NON-FINAL ACTION WRITTEN
01/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
01/01/2021
DOCK
ASSIGNED TO EXAMINER
12/30/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/28/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/24/2020
Continuous trademark protection
Get notified about every new filing that threatens GENEHOME BUILT BY BLUEBIRD BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.